ahlam1399
02-25-2016, 11:41 PM
Kannalife eyes share float to fund cannabis-based medicine
(Reuters) - Kannalife Sciences Inc is considering an initial public offering this year to fund development of a cannabis-based treatment for a brain disorder that affects 200,000 Americans, its chief executive said.
http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4ddabec3/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=Uc-ldENU3AU:hxvnjBsfAxk:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=Uc-ldENU3AU:hxvnjBsfAxk:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=Uc-ldENU3AU:hxvnjBsfAxk:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=Uc-ldENU3AU:hxvnjBsfAxk:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=Uc-ldENU3AU:hxvnjBsfAxk:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/Uc-ldENU3AU
(Reuters) - Kannalife Sciences Inc is considering an initial public offering this year to fund development of a cannabis-based treatment for a brain disorder that affects 200,000 Americans, its chief executive said.
http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4ddabec3/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=Uc-ldENU3AU:hxvnjBsfAxk:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=Uc-ldENU3AU:hxvnjBsfAxk:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=Uc-ldENU3AU:hxvnjBsfAxk:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=Uc-ldENU3AU:hxvnjBsfAxk:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=Uc-ldENU3AU:hxvnjBsfAxk:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/Uc-ldENU3AU